• Home
  • A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer.

A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer.

Author List
Clément-Duchêne C, Natale RB, Jahan T, Krupitskaya Y, Osarogiagbon R, Sanborn RE, Bernstein ED, Dudek AZ, Latz JE, Shi P, Wakelee HA
Publication
Lung cancer (Amsterdam, Netherlands)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1163247
Publication Year
2012
PubMed ID
22809813